Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$162.63 - $243.44 $92,373 - $138,273
-568 Reduced 10.57%
4,808 $818,000
Q2 2023

Jul 05, 2023

BUY
$172.91 - $232.22 $174,639 - $234,542
1,010 Added 23.13%
5,376 $1.2 Million
Q1 2023

Apr 06, 2023

BUY
$208.49 - $290.15 $352,556 - $490,643
1,691 Added 63.21%
4,366 $965,000
Q4 2022

Jan 09, 2023

BUY
$214.02 - $325.38 $572,503 - $870,391
2,675 New
2,675 $580,000
Q2 2022

Jul 20, 2022

BUY
$187.76 - $270.92 $370,826 - $535,067
1,975 Added 89.77%
4,175 $872,000
Q1 2022

Apr 20, 2022

SELL
$172.09 - $246.0 $77,440 - $110,700
-450 Reduced 16.98%
2,200 $487,000
Q4 2021

Jan 05, 2022

SELL
$214.16 - $283.8 $5,354 - $7,095
-25 Reduced 0.93%
2,650 $619,000
Q3 2021

Oct 08, 2021

SELL
$167.91 - $244.03 $386,193 - $561,269
-2,300 Reduced 46.23%
2,675 $586,000
Q2 2021

Jul 15, 2021

BUY
$143.7 - $176.01 $714,907 - $875,649
4,975 New
4,975 $838,000
Q3 2020

Oct 08, 2020

SELL
$75.75 - $100.45 $795,375 - $1.05 Million
-10,500 Closed
0 $0
Q2 2020

Jul 15, 2020

SELL
$52.7 - $86.74 $50,065 - $82,403
-950 Reduced 8.3%
10,500 $811,000
Q1 2020

Jun 15, 2020

BUY
$50.9 - $94.31 $582,805 - $1.08 Million
11,450 New
11,450 $645,000
Q3 2019

Nov 04, 2019

SELL
$59.3 - $75.53 $189,760 - $241,696
-3,200 Closed
0 $0
Q2 2019

Jul 09, 2019

SELL
$63.3 - $86.94 $117,105 - $160,839
-1,850 Reduced 36.63%
3,200 $225,000
Q1 2019

Apr 03, 2019

SELL
$72.69 - $92.28 $3,634 - $4,614
-50 Reduced 0.98%
5,050 $414,000
Q4 2018

Jan 11, 2019

BUY
$73.13 - $107.99 $372,963 - $550,749
5,100 New
5,100 $393,000
Q3 2018

Oct 03, 2018

SELL
$90.9 - $106.6 $454,500 - $533,000
-5,000 Closed
0 $0
Q2 2018

Jul 05, 2018

SELL
$88.96 - $104.92 $40,032 - $47,214
-450 Reduced 8.26%
5,000 $472,000
Q1 2018

Apr 17, 2018

BUY
$89.56 - $137.45 $488,102 - $749,102
5,450 New
5,450 $505,000

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $10.5B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.